Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-25-003637
Filing Date
2025-08-14
Accepted
2025-08-14 16:08:04
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 8826
  Complete submission text file 0000902664-25-003637.txt   10846
Mailing Address 277 PARK AVE 23RD FLOOR NEW YORK NY 10172
Business Address 277 PARK AVE 23RD FLOOR NEW YORK NY 10172 2122872500
HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by) CIK: 0000919185 (see all company filings)

EIN.: 134131516 | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address 10080 N WOLFE ROAD SUITE SW3-200 CUPERTINO CA 95014
Business Address 10080 N WOLFE ROAD SUITE SW3-200 CUPERTINO CA 95014 4085018881
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Subject) CIK: 0001742927 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-90624 | Film No.: 251218942
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)